Published July 26, 2021 | Version HCC_CEMS_CANCER_v.1
Journal article Open

Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma

  • 1. Department of Gastroenterology and Hepatology, University Hospital Coventry, UK
  • 2. Mosaiques Diagnostics GmbH, Germany
  • 3. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Germany
  • 4. Arden Tissue Bank, University Hospital Coventry, UK
  • 5. Department of Pathology, University Hospital Coventry, UK

Description

In this study, the application of capillary electrophoresis mass spectrometry enabled identification of 31 urinary peptides significantly associated with hepatocellular carcinoma diagnosis and prognosis. Further assessment of these peptides leads to prediction of cellular proteases involved in their development namely Meprin A subunit α and Kallikrein-6. Subsequent identification of the proteases was verified by immunohistochemistry in normal liver, cirrhosis and hepatocellular carcinoma. Histopathological assessment of the proteases revealed numerical gradient staining signifying their involvement in liver fibrosis and hepatocellular carcinoma formation. The discovered urinary peptides offer a potential noninvasive tool for diagnosis and prognosis of hepatocellular carcinoma.

Notes

195 CE-MS Raw Data Files, uncalibrated, assignment to the patient groups HCC (n=57), liver disease with liver cirrhosis (n=72), liver disease without cirrhosis (n=57), no liver disease (n=9) as indicated in the attached Excel-List.

Files

Files (55.1 GB)

Name Size Download all
md5:928a68770196b76386b1448ef475c12d
55.1 GB Download